Caixin China Biz Roundup: Chinese mRNA Jab Activates 80% to 95% Immune Response

Behind the findings of the homegrown shot’s first stage clinical trials; Beijing’s plan to stay smog-free over the Olympics; and China digests a record amount of bad assets. Are you a big fan of our shows? Then please give our podcast account, China Business Insider, a 5-star rating on Spotify, Apple, or wherever you listen to podcasts!